Dragomabin
Chemical compound
From Wikipedia, the free encyclopedia
Dragomabin is a lipopeptide isolated from the marine cyanobacteria Lyngbya majuscula.[1] It has in vitro antimalarial activity.[1] In 2018, a laboratory synthesis of dragomabin was reported.[2] The synthesis identified a misassignment of the configuration of the stereogenic center on the alkyne-bearing fragment and it was revised from (S) to (R).[2]
| Identifiers | |
|---|---|
| |
3D model (JSmol) |
|
| ChEBI |
|
| ChEMBL |
|
| ChemSpider |
|
PubChem CID |
|
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C37H51N5O6 | |
| Molar mass | 661.844 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
